GRI Bio Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio’s program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
/ 
Frequently asked questions
To buy GRI Bio Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for GRI Bio Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for GRI Bio Inc. is GRI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
GRI Bio Inc. has its primary listing on NASDAQ (Small cap). You can trade GRI Bio Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, GRI Bio Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include GRI Bio Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like GRI Bio Inc..